Skip to main content
SpringerLink
Log in

Rheumatoid Arthritis and Spondyloarthritis

  • Chapter
  • First Online:
Principles of Osteoimmunology

  • 513 Accesses

Abstract

Recent years have seen extraordinary growth in our knowledge and understanding of the pathogenesis of inflammatory arthritis as reflected in the development of new therapies and changing clinical practice. This chapter will review the most common forms of inflammatory arthritis, including rheumatoid arthritis, the axial spondyloarthritides (radiographic axial spondyloarthritis (r-axSpA) and the non-radiographic axial spondyloarthritis (nr-axSpA)) as well as psoriatic arthritis (PsA) to explore their epidemiology, pathogenesis, clinical features and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abu-Amer Y, Erdmann J, Alexopoulou L, Kollias G, Ross FP, Teitelbaum SL (2000) Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. J Biol Chem 275:27307–27310

    CAS  PubMed  Google Scholar 

  • Aceves-Avila FJ, Baez-Molgado S, Medina F, Fraga A (1998) Paleopathology in osseous remains from the 16th century. A survey of rheumatic diseases. J Rheumatol 25:776–782

    CAS  PubMed  Google Scholar 

  • Alamanos Y, Voulgari PV, Drosos AA (2006) Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of rheumatology criteria: a systematic review. Semin Arthritis Rheum 36:182–188

    Article  PubMed  Google Scholar 

  • Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum (9):2569–2581

    Google Scholar 

  • Amor B, Santos RS, Nahal R, Listrat V, Dougados M (1994) Predictive factors for the long-term outcome of spondyloarthropathies. J Rheumatol 21:1883–1887

    CAS  PubMed  Google Scholar 

  • Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M (2001) Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 44:1876–1886

    Article  CAS  PubMed  Google Scholar 

  • Appel H, Ruiz-Heiland G, Listing J, Zwerina J, Herrmann M, Mueller R, Haibel H, Baraliakos X, Hempfing A, Rudwaleit M, Sieper J, Schett G (2009) Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum 60:3257–3262

    Article  PubMed  Google Scholar 

  • Appelboom T, de Boelpaepe C, Ehrlich GE, Famaey J-P (1981) Rubens and the question of antiquity of rheumatoid arthritis. JAMA 245:483–486

    Article  CAS  PubMed  Google Scholar 

  • Atagunduz P, Appel H, Kuon W, Wu P, Thiel A, Kloetzel PM, Sieper J (2005) Hla-b27-restricted cd8+ t cell response to cartilage-derived self peptides in ankylosing spondylitis. Arthritis Rheum 52:892–901

    Article  CAS  PubMed  Google Scholar 

  • Attia EA, Khafagy A, Abdel-Raheem S, Fathi S, Saad AA (2011) Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity. Int J Dermatol 50:30–35

    Article  PubMed  Google Scholar 

  • Aydin SZ, Ash ZR, Tinazzi I, Castillo-Gallego C, Kwok C, Wilson C (2012) The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development 72(6):992–995. doi: 10.1136/annrheumdis-2012-201617. Epub 2012 Aug 3

    Google Scholar 

  • Ball J (1971) Enthesopathy of rheumatoid and ankylosing spondylitis. Ann Rheum Dis 30:213–223

    Google Scholar 

  • Baraliakos X, Listing J, Rudwaleit M et al (2005) Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab. Ann Rheum Dis 64:1462–1466

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Baraliakos X, Borah B, Braun J, Baeten D, Laurent D, Sieper J, Emery P, McInnes IB, van Laar JM, Wordsworth P, Wollenhaupt J, Kellner H, Colin L, Vandenhende F, Radford K, Hueber W (2015) Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study. Ann Rheum Dis 75:408–412

    Article  PubMed  Google Scholar 

  • Baron R, Rawadi G, Roman-Roman S (2006) Wnt signaling: a key regulator of bone mass. Curr Top Dev Biol 76:103–127

    Article  CAS  PubMed  Google Scholar 

  • Benjamin M, Toumi H, Suzuki D, Redman S, Emery P, McGonagle D (2007) Microdamage and altered vascularity at the enthesis-bone interface provides an anatomic explanation for bone involvement in the hla-b27-associated spondylarthritides and allied disorders. Arthritis Rheum 56:224–233

    Article  CAS  PubMed  Google Scholar 

  • Bergman GJ, Hochberg MC, Boers M, Wintfeld N, Kielhorn A, Jansen JP (2010) Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs. Semin Arthritis Rheum 39(6):425–441

    Article  CAS  PubMed  Google Scholar 

  • Boers M, Verhoeven AC, Markusse HM, van de Laar MAFJ, Westhovens R, van Denderen JC, van Zeben D, Dijkmans BAC, Peeters AJ, Jacobs P, van den Brink HR, Schouten HJA, van der Heijde DMFM, Boonen A, van der Linden S (1997) Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 350:309–318

    Article  CAS  PubMed  Google Scholar 

  • Borman P, Babaoglu S, Gur G, Bingol S, Bodur H (2008) Bone mineral density and bone turnover in patients with psoriatic arthritis. Clin Rheumatol 27:443–447

    Article  PubMed  Google Scholar 

  • Bottini N, Vang T, Cucca F, Mustelin T (2006) Role of ptpn22 in type 1 diabetes and other autoimmune diseases. Semin Immunol 18:207–213

    Article  CAS  PubMed  Google Scholar 

  • Brandt J, Khariouzov A, Listing J, Haibel H, Sorensen H, Grassnickel L, Rudwaleit M, Sieper J, Braun J (2003) Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Arthritis Rheum 48:1667–1675

    Article  CAS  PubMed  Google Scholar 

  • Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, Gromnica-Ihle E, Kellner H, Krause A, Schneider M, Sorensen H, Zeidler H, Thriene W, Sieper J (2002) Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 359:1187–1193

    Article  CAS  PubMed  Google Scholar 

  • Braun J, van den Berg R, Baraliakos X et al (2011) 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70:896–904

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DCO, Sturrock RD (1973) Ankylosing spondylitis and hl-a 27. Lancet 301:904–907

    Article  Google Scholar 

  • Brown MA, Brophy S, Bradbury L, Hamersma J, Timms A, Laval S, Cardon L, Calin A, Word- sworth BP (2003) Identification of major loci controlling clinical manifestations of ankylosing spondylitis. Arthritis Rheum 48:2234–2239

    Article  PubMed  Google Scholar 

  • Burmester GR, Rigby WF, van Vollenhoven RF, Kay J, Rubbert-Roth A, Kelman A, Dimonaco S, Mitchell N (2015) Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial. Ann Rheum Dis. 2016;75(6):1081–1091

    Google Scholar 

  • Burton PR, Clayton DG, Cardon LR, Craddock N, Celoukas P, Duncanson A (2007) Association scan of 14,500 nonsynonymous snps in four diseases identifies autoimmunity variants. Nat Genet 39:1329–1337

    Article  CAS  PubMed  Google Scholar 

  • Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 21:2281–2285

    CAS  PubMed  Google Scholar 

  • Calin A, Dijkmans BA, Emery P, Hakala M, Kalden J, Leirisalo-Repo M, Mola EM, Salvarani C, Sanmarti R, Sany J, Sibilia J, Sieper J, van der Linden S, Veys E, Appel AM, Fatenejad S (2004) Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis 63:1594–1600

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen XX, Baum W, Dwyer D, Stock M, Schwabe K, Ke HZ, Stolina M, Schett G, Bozec A (2013) Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis. Ann Rheum Dis 72(10):1732–1736

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Clegg DO, Reda DJ, Weisman MH et al (1996) Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A department of veterans affairs cooperative study. Arthritis Rheum 39:2004–2012

    Article  CAS  PubMed  Google Scholar 

  • Cloutier JF, Veillette A (1999) Cooperative inhibition of t-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 189:111–121

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, van der Heijde D, Zhou L, Tsuji W, Newmark R (2008) Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase ii clinical trial. Arthritis Rheum 58:1299–1309

    Article  CAS  PubMed  Google Scholar 

  • Colmegna I, Diaz-Borjon A, Fujii H, Schaefer L, Goronzy JJ, Weyand CM (2008) Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum 58:990–1000

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Corli J, Flipo RM, Philippe P, Bera-Louville A, Béhal H, Wibaux C, Paccou J (2015) Tumor necrosis factor-α inhibition in ankylosing spondylitis and nonradiographic axial spondyloarthritis: treatment response, drug survival, and patient outcome. J Rheumatol 42:2376–2382

    Article  CAS  PubMed  Google Scholar 

  • Cutolo M, Lahita RG (2005) Estrogens and arthritis. Rheum Dis Clin North Am 31:19–27

    Article  PubMed  Google Scholar 

  • D’Epiro S, Marocco C, Salvi M, Mattozzi C, Luci C, Macaluso L, Giancristoforo S, Campoli M, Scarnò M, Migliaccio S, Calvieri S, Richetta A (2014) Psoriasis and bone mineral density: implications for long-term patients. J Dermatol 41(9):783–787

    Article  PubMed  Google Scholar 

  • Daoussis D, Liossis SN, Solomou EE, Tsanaktsi A, Bounia K, Karampetsou M, Yiannopoulos G, Andonopoulos AP (2010) Evidence that dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum 62:150–158

    Article  CAS  PubMed  Google Scholar 

  • David JP, Schett G (2010) Tnf and bone. Curr Dir Autoimmun 11:135–144

    Article  CAS  PubMed  Google Scholar 

  • Davis JC Jr, Van Der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, Kivitz A, Fleischmann R, Inman R, Tsuji W (2003) Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum 48:3230–3236

    Article  CAS  PubMed  Google Scholar 

  • de Vries-Bouwstra J, Le Cessie S, Allaart C, Breedveld F, Huizinga T (2006) Using predicted disease outcome to provide differentiated treatment of early rheumatoid arthritis. J Rheumatol 33:1747–1753

    PubMed  Google Scholar 

  • Del Puente A, Esposito A, Costa L, Benigno C, Del Puente A, Foglia F, Oriente A, Bottiglieri P, Caso F, Scarpa R (2015) Fragility fractures in patients with psoriatic arthritis. J Rheumatol Suppl 93:36–39

    Article  PubMed  Google Scholar 

  • Duarte GV, Faillace C, Freire de Carvalho J (2012) Psoriatic arthritis. Best Pract Res Clin Rheumatol 26(1):147–156. doi: 10.1016/j.berh.2012.01.003

    Google Scholar 

  • Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, Korb A, Smolen J, Hoffmann M, Scheinecker C, van der Heide D, Landewe R, Lacey D, Richards WG, Schett G (2007) Dick- kopf-1 is a master regulator of joint remodeling. Nat Med 13:156–163

    Article  CAS  PubMed  Google Scholar 

  • Dirven L, van den Broek M, van Groenendael JH et al (2012) Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis. BMC Musculoskelet Disord 13:125

    Article  PubMed  PubMed Central  Google Scholar 

  • Dong W, Zhang Y, Yan M, Liu H, Chen Z, Zhu P (2008) Upregulation of 78-kda glucose-regulated protein in macrophages in peripheral joints of active ankylosing spondylitis. Scand J Rheumatol 37:427–434

    Article  CAS  PubMed  Google Scholar 

  • Dougados M, vam der Linden S, Leirisalo-Repo M, Huitfeldt B, Juhlin R, Veys E, Zeidler H, Kvien TK, Olivieri I, Dijkmans B et al (1995) Sulfasalazine in the treatment of spondylarthropa- thy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 38:618–627

    Article  CAS  PubMed  Google Scholar 

  • Dougados M, van der Heijde D, Sieper J et al (2013) Clinical and imaging efficacy of etanercept in early non-radiographic axial spondyloarthritis: a 12-week, randomized, double-blind, placebo-controlled trial. Ann Rheum Dis 72(Suppl 3):A87–A88

    Google Scholar 

  • Eder L, Thavaneswaran A, Chandran V et al (2014) Tumour necrosis factor α blockers are more effective than methotrexate in the inhibition of radiographic joint damage progression among patients with psoriatic arthritis. Ann Rheum Dis 73:1007–1011

    Article  CAS  PubMed  Google Scholar 

  • Fénix-Caballero S, Alegre-del Rey EJ, Castaño-Lara R et al (2013) Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis. J Clin Pharm Ther 38:286–293

    Article  PubMed  CAS  Google Scholar 

  • Fernández-Espartero C, de Miguel E, Loza E et al (2014) Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme. Ann Rheum Dis 73:1350–1355

    Article  PubMed  Google Scholar 

  • Finzel S, Englbrecht M, Engelke K, Stach C, Schett G (2011) A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis. Ann Rheum Dis 70(1):122–127

    Article  PubMed  Google Scholar 

  • François RJ, Neure L, Sieper J, Braun J (2006) Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor α in two patients with early disease and transforming growth factor β in three more advanced cases. Ann Rheum Dis 65:713–720

    Article  PubMed  CAS  Google Scholar 

  • Franklin EC, Molman HR, Muller-Eberhard HJ, Kunkel HB (1957) An unusual protein component of high molecular weight in the serum of certain patients with rheumatoid arthritis. J Exp Med 105:425–435

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Frediani B, Allegri A, Falsetti P et al (2001) Bone mineral density in patients with psoriatic arthritis. J Rheumatol 28:138–143

    CAS  PubMed  Google Scholar 

  • Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR (2007) Autoimmune inflammation from the th17 perspective. Autoimmun Rev 6:169–175

    Article  CAS  PubMed  Google Scholar 

  • Gabriel S, Michaud K (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 11:229. doi:10.1186/ar2669

    Article  PubMed  PubMed Central  Google Scholar 

  • Gaujoux-Viala C, Smolen JS, Landewé R, Dougados M, Kvien TK, Mola EM, Scholte-Voshaar M, van Riel P, Gossec L (2010) Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the eular recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 69:1004–1009

    Article  CAS  PubMed  Google Scholar 

  • Ghozlani I, Ghazi M, Nouijai A, Mounach A, Rezqi A, Achemlal L, Bezza A, Maghraoui AE (2009) Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone 44:772–776

    Article  CAS  PubMed  Google Scholar 

  • Girbal-Neuhauser E, Durieux J-J, Arnaud M, Dalbon P, Sebbag M, Vincent C, Simon M, Senshu T, Masson-Bessiere C, Jolivet-Reynaud C, Jolivet M, Serre G (1999) The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 162:585–594

    CAS  PubMed  Google Scholar 

  • Glant TT, Mikecz K, Arzoumanian A, Poole AR (1987) Proteoglycan-induced arthritis in balb/c mice. Clinical features and histopathology. Arthritis Rheum 30:201–212

    Article  CAS  PubMed  Google Scholar 

  • Glintborg B, Østergaard M, Dreyer L et al (2011) Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registry. Arthritis Rheum 63:382–390

    Article  PubMed  Google Scholar 

  • Goie The HS, Steven MM, van der Linden SM, Cats A (1985) Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol 24:242–249

    Article  CAS  PubMed  Google Scholar 

  • Gorman JD, Sack KE, Davis JC Jr (2002) Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 346:1349–1356

    Article  CAS  PubMed  Google Scholar 

  • Gossec L, Smolen JS, Gaujoux-Viala C et al (2012) European league against rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis 71:4–12

    Article  CAS  PubMed  Google Scholar 

  • Gottlieb A, Narang K (2013) Ustekinumab in the treatment of psoriatic arthritis: latest findings and clinical potential. Ther Adv Musculoskelet Dis 5:277–285

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gregersen PK, Silver J, Winchester RJ (1987) The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 30:1205–1213

    Article  CAS  PubMed  Google Scholar 

  • Gu MM, Yuan WT, Yang JQ, Zhang J, Xiong XY, Yao FJ, Lu ZY, Wang ZG, Huang W, Fan LA (2004) A genomewide scan for the susceptibility gene loci to ankylosing spondylitis in Chinese han population. Yi Chuan Xue Bao 31:217–220

    CAS  PubMed  Google Scholar 

  • Haibel H, Heldmann F, Braun J et al (2013) Long-term efficacy of adalimumab after drug withdrawal and retreatment in patients with active non-radiographically evident axial spondyloarthritis who experience a flare. Arthritis Rheum 65:2211–2213

    Article  CAS  PubMed  Google Scholar 

  • Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, Jakobsson PJ, Baum W, Nimmerjahn F, Szarka E, Sarmay G, Krumbholz G, Neumann E, Toes R, Scherer HU, Catrina AI, Klareskog L, Jurdic P, Schett G (2012) Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 122(5):1791–1802

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Harre U, Lang SC, Pfeifle R, Rombouts Y, Frühbeißer S, Amara K, Bang H, Lux A, Koeleman CA, Baum W, Dietel K, Gröhn F, Malmström V, Klareskog L, Krönke G, Kocijan R, Nimmerjahn F, Toes RE, Herrmann M, Scherer HU, Schett G (2015) Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. Nat Commun 6:6651

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Harrison MJ, Tricker KJ, Davies L, Hassell A, Dawes P, Scott DL, Knight S, Davis M, Mulherin D, Symmons DPM (2005) The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis. J Rheumatol 32:2330–2336

    PubMed  Google Scholar 

  • Haschka J, Englbrecht M, Hueber AJ, Manger B, Kleyer A, Reiser M et al (2016) Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study. Ann Rheum Dis 75:45–51

    Article  PubMed  Google Scholar 

  • Hetland ML, Ejbjerg B, Horslev-Petersen K et al (2009) Mri bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (cimestra). Ann Rheum Dis 68:384–390

    Article  CAS  PubMed  Google Scholar 

  • Ince G, Sarpel T, Durgun B, Erdogan S (2006) Effects of a multimodal exercise program for people with ankylosing spondylitis. Phys Ther 86:924–935

    PubMed  Google Scholar 

  • Jarvinen P (1995) Occurrence of ankylosing spondylitis in a nationwide series of twins. Arthritis Rheum 38:381–383

    Article  CAS  PubMed  Google Scholar 

  • Jones G, Crotty M, Brooks P (2000) Interventions for psoriatic arthritis. Cochrane Database Syst Rev (3):CD000212

    Google Scholar 

  • Jørgensen KT, Wiik A, Pedersen M, Hedegaard CJ, Vestergaard BF, Gislefoss RE, Kvien TK, Wohl- fahrt J, Bendtzen K, Frisch M (2008) Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case–control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis 67:860–866

    Article  PubMed  CAS  Google Scholar 

  • Kaltenhauser S, Pierer M, Arnold S, Kamprad M, Baerwald C, Hantzschel H, Wagner U (2007) Antibodies against cyclic citrullinated peptide are associated with the drb1 shared epitope and predict joint erosion in rheumatoid arthritis. Rheumatology 46:100–104

    Article  CAS  PubMed  Google Scholar 

  • Kavanaugh A, McInnes I, Mease P et al (2009) Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: twenty-four-week efficacy and safety results of a randomized, placebo-controlled study. Arthritis Rheum 60:976–986

    Article  CAS  PubMed  Google Scholar 

  • Kavanaugh A, Ritchlin C, Rahman P et al (2014a) Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials. Ann Rheum Dis 73:1000–1006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kavanaugh A, Mease PJ, Gomez-Reino JJ et al (2014b) Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor. Ann Rheum Dis 73:1020–1026

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kavanaugh A, Puig L, Gottlieb AB, Ritchlin C, Li S, Wang Y, Mendelsohn AM, Song M, Zhu Y, Rahman P, McInnes IB, PSUMMIT I Study Group (2015) Maintenance of clinical efficacy and radiographic benefit through 2 years of ustekinumab therapy in patients with active psoriatic arthritis: results from the PSUMMIT 1 trial. Arthritis Care Res (Hoboken) 67:1739–1749

    Article  CAS  Google Scholar 

  • Khan MA (2000) Update: the twenty subtypes of hla-b27. Curr Opin Rheumatol 12:235–238

    Article  CAS  PubMed  Google Scholar 

  • Kidd BL, Cawley MI (1988) Delay in diagnosis of spondarthritis. Br J Rheumatol 27:230–232

    Article  CAS  PubMed  Google Scholar 

  • Kim N, Kadono Y, Takami M, Lee J, Lee SH, Okada F, Kim JH, Kobayashi T, Odgren PR, Nakano H, Yeh WC, Lee SK, Lorenzo JA, Choi Y (2005) Osteoclast differentiation independent of the trance-rank-traf6 axis. J Exp Med 202:589–595

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim SY, Schneeweiss S, Liu J et al (2010) Risk of osteoporotic fracture in a large population based cohort of patients with rheumatoid arthritis. Arthritis Res Ther 12(4):R154

    Article  PubMed  PubMed Central  Google Scholar 

  • Kingsley GH, Kowalczyk A, Taylor H et al (2012) A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. Rheumatology (Oxford) 51:1368–1377

    Article  CAS  Google Scholar 

  • Klareskog L, Padyukov L, Ronnelid J, Alfredsson L (2006) Genes, environment and immunity in the development of rheumatoid arthritis. Curr Opin Rheumatol 18:650–655

    CAS  Google Scholar 

  • Klareskog L, Padyukov L, Alfredsson L (2007) Smoking as a trigger for inflammatory rheumatic diseases. Curr Opin Rheumatol 19:49–54

    Article  CAS  PubMed  Google Scholar 

  • Kleyer A, Finzel S, Rech J, Manger B, Krieter M, Faustini F, Araujo E, Hueber AJ, Harre U, Engelke K, Schett G (2014) Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann Rheum Dis 73(5):854–860

    Article  PubMed  Google Scholar 

  • Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T (2000) Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the odf/rankl-rank interaction. J Exp Med 191:275–286

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kocijan R, Finzel S, Englbrecht M, Engelke K, Rech J, Schett G (2014a) Decreased quantity and quality of the periarticular and non-periarticular bone in patients with rheumatoid arthritis: a cross-sectional HR-pQCT study. J Bone Miner Res 29(4):1005–1014

    Article  PubMed  Google Scholar 

  • Kocijan R, Finzel S, Englbrecht M, Engelke K, Rech J, Schett G (2014b) Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity. Ann Rheum Dis 73(11):2022–2028

    Article  PubMed  Google Scholar 

  • Kocijan R, Englbrecht M, Haschka J, Simon D, Kleyer A, Finzel S, Kraus S, Resch H, Muschitz C, Engelke K, Sticherling M, Rech J, Schett G (2015) Quantitative and qualitative changes of bone in psoriasis and psoriatic arthritis patients. J Bone Miner Res 30:1775–1783

    Article  PubMed  Google Scholar 

  • Kollnberger S, Bird LA, Roddis M, Hacquard-Bouder C, Kubagawa H, Bodmer HC, Breban M, McMichael AJ, Bowness P (2004) Hla-b27 heavy chain homodimers are expressed in hla-b27 transgenic rodent models of spondyloarthritis and are ligands for paired ig-like receptors. J Immunol 173:1699–1710

    Article  CAS  PubMed  Google Scholar 

  • Lambert RG, Salonen D, Rahman P, Inman RD, Wong RL, Einstein SG, Thomson GT, Beaulieu A, Choquette D, Maksymowych WP (2007) Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 56:4005–4014

    Article  CAS  PubMed  Google Scholar 

  • Landewé R, Braun J, Deodhar A et al (2014) Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled phase 3 study. Ann Rheum Dis 73:39–47

    Article  PubMed  CAS  Google Scholar 

  • Lau CS, Burgos-Vargas R, Louthrenoo W, Mok MY, Wordsworth P, Zeng QY (1998) Features of spondyloarthritis around the world. Rheum Dis Clin North Am 24:753–770

    Article  CAS  PubMed  Google Scholar 

  • Laval SH, Timms A, Edwards S, Bradbury L, Brophy S, Milicic A, Rubin L, Siminovitch KA, Weeks DE, Calin A, Wordsworth BP, Brown MA (2001) Whole-genome screening in ankylosing spondylitis: evidence of non-mhc genetic-susceptibility loci. Am J Hum Genet 68:918–926

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A (2002) Chromatin-igg complexes activate b cells by dual engagement of igm and toll-like receptors. Nature 416:603–607

    Article  CAS  PubMed  Google Scholar 

  • Lu X, Gilbert L, He X, Rubin J, Nanes MS (2006) Transcriptional regulation of the osterix (osx, sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and nf kappa b pathways. J Biol Chem 281:6297–6306

    Article  CAS  PubMed  Google Scholar 

  • Lundy S, Sarkar S, Tesmer L, Fox D (2007) Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res Ther 9:202

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Magrey M, Khan MA (2010) Osteoporosis in ankylosing spondylitis. Curr Rheumatol Rep 12:332–336

    Article  PubMed  Google Scholar 

  • Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClercq S, Chiu P, Yan A, Skeith KJ, Aaron SL, Homik J, Davis P, Sholter D, Russell AS (2002) A six-month randomized, controlled, double- blind, dose–response comparison of intravenous pamidronate (60mg versus 10mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. Arthritis Rheum 46:766–773

    Article  CAS  PubMed  Google Scholar 

  • Manfredsdottir VF, Vikingsdottir T, Jonsson T, Geirsson AJ, Kjartansson O, Heimisdottir M, Sigurdardottir SL, Valdimarsson H, Vikingsson A (2006) The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology 45:734–740

    Article  CAS  PubMed  Google Scholar 

  • McCloskey E, Johansson H, Oden A, Kanis JA (2012) Fracture risk assessment. Clin Biochem 45(12):887–893

    Article  PubMed  Google Scholar 

  • McInnes IB, Sieper J, Braun J et al (2014) Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of concept trial. Ann Rheum Dis 73:349–356

    Article  CAS  PubMed  Google Scholar 

  • Mease PJ, Goffe BS, Metz J et al (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356:385–390

    Article  CAS  PubMed  Google Scholar 

  • Mease PJ, McInnes IB, Kirkham B, Kavanaugh A, Rahman P, van der Heijde D, Landewé R, Nash P, Pricop L, Yuan J, Richards HB, Mpofu S, FUTURE 1 Study Group (2015) Secukinumab Inhibition of Interleukin-17A in patients with psoriatic arthritis. N Engl J Med 373(14):1329–1339

    Article  CAS  PubMed  Google Scholar 

  • Mikecz K, Glant TT, Baron M, Poole AR (1988) Isolation of proteoglycan-specific t lymphocytes from patients with ankylosing spondylitis. Cell Immunol 112:55–63

    Article  CAS  PubMed  Google Scholar 

  • Millard TP, Antoniades L, Evans AV, Smith HR, Spector TD, Barker JN (2001) Bone mineral density of patients with chronic plaque psoriasis. Clin Exp Dermatol 26:446–448

    Article  CAS  PubMed  Google Scholar 

  • Möttönen T, Hannonen P, Leirisalo-Repo M, Nissilä M, Kautiainen H, Korpela M, Laasonen L, Julkunen H, Luukkainen R, Vuori K, Paimela L, BlÃ¥field H, Hakala M, Ilva K, Yli-Kerttula U, Puolakka K, Järvinen P, Hakola M, Piirainen H, Ahonen J, Pälvimäki I, Forsberg S, Koota K, Friman C (1999) Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. Lancet 353:1568–1573

    Article  PubMed  Google Scholar 

  • Nakamura I, Kadono Y, Takayanagi H, Jimi E, Miyazaki T, Oda H, Nakamura K, Tanaka S, Rodan GA, le Duong T (2002) Il-1 regulates cytoskeletal organization in osteoclasts via tnf receptor- associated factor 6/c-src complex. J Immunol 168:5103–5109

    Article  CAS  PubMed  Google Scholar 

  • Nam JL, Winthrop KL, van Vollenhoven RF, Pavelka K, Valesini G, Hensor EMA, Worthy G, Landewé R, Smolen JS, Emery P, Buch MH (2010) Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the eular recommendations for the management of RA. Ann Rheum Dis 2010;69(6):976–986. doi:10.1136/ard.2009.126573

    Google Scholar 

  • Neidhart M, Baraliakos X, Seemayer C, Zelder C, Gay RE, Michel BA, Boehm H, Gay S, Braun J (2009) Expression of cathepsin k and matrix metalloproteinase 1 indicate persistent osteode- structive activity in long-standing ankylosing spondylitis. Ann Rheum Dis 68:1334–1339

    Article  CAS  PubMed  Google Scholar 

  • Nepom GT (1989) Hla genes associated with rheumatoid arthritis: identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 32:15–21

    Article  CAS  PubMed  Google Scholar 

  • Nolla JM, Fiter J, Rozadilla A et al (1999) Bone mineral density in patients with peripheral psoriatic arthritis. Rev Rhum Engl Ed 66:457–461

    CAS  PubMed  Google Scholar 

  • Rashid T, Ebringer A (2007) Ankylosing spondylitis is linked to klebsiella – the evidence. Clin Rheumatol 26:858–864

    Article  PubMed  Google Scholar 

  • Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE, Balish E, Taurog JD, Hammer RE, Wilson KH, Sartor RB (1996) Normal luminal bacteria, especially bacteroides species, mediate chronic colitis, gastritis, and arthritis in hla-b27/human beta2 microglobulin transgenic rats. J Clin Invest 98:945–953

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rauner M, Stupphann D, Haas M, Fert I, Glatigny S, Sipos W, Breben M, Pietschmann P (2009) The hla-b27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased rankl to osteoprotegerin mrna ratio. J Rheumatol 36:120–126

    PubMed  Google Scholar 

  • Raza K, Falciani F, Curnow SJ, Ross E, Lee C-Y, Akbar A, Lord J, Gordon C, Buckley C, Salmon M (2005) Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of t cell and stromal cell origin. Arthritis Res Ther 7:R784–R795

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Riesco M, Manzano F, Font P, Garcia A, Nolla JM (2013) Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures. Clin Rheumatol 32:1799–1804

    Article  PubMed  Google Scholar 

  • Ritchlin CT, Kavanaugh A, Gladman DD et al (2009) Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 68:1387–1394

    Article  CAS  PubMed  Google Scholar 

  • Rossini M, Viapiana O, Adami S, Fracassi E, Idolazzi L, Dartizio C, Povino MR, Orsolini G, Gatti D (2015) In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density. Clin Exp Rheumatol 33(1):77–83

    PubMed  Google Scholar 

  • Rothschild BM, Turner KR, DeLuca MA (1988) Symmetrical erosive peripheral polyarthritis in the late archaic period of alabama. Science 241:1498–1501

    Article  CAS  PubMed  Google Scholar 

  • Rudwaleit M, Sieper J (2012) Referral strategies for early diagnosis of axial spondyloarthritis. Nat Rev Rheumatol 8:262–268

    Article  CAS  PubMed  Google Scholar 

  • Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J et al (2009) The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783. doi: 10.1136/ard.2009.108233. Epub 2009 Mar 17

    Google Scholar 

  • Rudwaleit M, van der Heijde D, Landewé R et al (2011) TheAssessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70:25–31

    Article  CAS  PubMed  Google Scholar 

  • Sanmartí R, Gómez-Centeno A, Ercilla G, Larrosa M, Viñas O, Vazquez I, Gómez-Puerta J, Gratacós J, Salvador G, Cañete J (2007) Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using dmards and very low doses of glucocorticoids. Clin Rheumatol 26:1111–1118

    Article  PubMed  Google Scholar 

  • Schlosstein L, Terasaki PI, Bluestone R, Pearson CM (1973) High association of an hl-a antigen, w27, with ankylosing spondylitis. N Engl J Med 288:704–706

    Article  CAS  PubMed  Google Scholar 

  • Sieper J, van der Heijde D, Dougados M et al (2012) Early response to adalimumab predicts long-term remission through 5 years of treatment in patients with ankylosing spondylitis. Ann Rheum Dis 71:700–706

    Article  CAS  PubMed  Google Scholar 

  • Sieper J, van der Heijde D, Dougados M et al (2013) Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1). Ann Rheum Dis 72:815–822

    Article  CAS  PubMed  Google Scholar 

  • Sieper J, Porter-Brown B, Thompson L et al (2014) Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials. Ann Rheum Dis 73:95–100

    Article  CAS  PubMed  Google Scholar 

  • Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, Vaysbrot E et al (2015) 2015 American College of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 68:1–26

    PubMed  Google Scholar 

  • Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 4:631–637

    Article  Google Scholar 

  • Smolen J, Braun J, Dougados M et al (2014) Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis 73:6–16

    Article  PubMed  Google Scholar 

  • Smolen JS, van Vollenhoven R, Kavanaugh A et al (2015) Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients. Arthritis Res Ther 17:245

    Google Scholar 

  • Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, Kvien TK et al (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 75(1):3–15

    Google Scholar 

  • Song IH, Weiß A, Hermann KG et al (2013) Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial. Ann Rheum Dis 72:823–825

    Article  CAS  PubMed  Google Scholar 

  • Stamp LK, O’Donnell JL, Chapman PT, Zhang M, Frampton C, James J, Barclay ML (2009) Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment. Arthritis Rheum 60:2248–2256

    Article  CAS  PubMed  Google Scholar 

  • Taurog JD, Hammer RE (1995) Experimental spondyloarthropathy in hla-b27 transgenic rats. Clin Rheumatol 15(Suppl 1):22–27

    Google Scholar 

  • Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673

    Article  PubMed  Google Scholar 

  • Turesson C, Matteson EL (2009) Vasculitis in rheumatoid arthritis. Curr Opin Rheumatol 21:35–40

    Article  PubMed  Google Scholar 

  • Tvete IF, Natvig B, GÃ¥semyr J, Meland N, Røine M, Klemp M (2015) Comparing effects of biologic agents in treating patients with rheumatoid arthritis: a multiple treatment comparison regression analysis. PLoS One 10(9):e0137258. doi:10.1371/journal.pone.0137258. eCollection

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • van den Bosch F, Baeten D, Kruithof E, De Keyser F, Mielants H, Veys EM (2001) Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha. Ann Rheum Dis 60(Suppl 3):iii33–iii36

    PubMed  PubMed Central  Google Scholar 

  • van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, Braun J (2005) Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (assert). Arthritis Rheum 52:582–591

    Article  PubMed  CAS  Google Scholar 

  • van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J, Dougados M, Reveille JD, Wong RL, Kupper H, Davis JC Jr (2006) Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo- controlled trial. Arthritis Rheum 54:2136–2146

    Article  PubMed  CAS  Google Scholar 

  • van der Heijde D, Salonen D, Weissman BN, Landewe R, Maksymowych WP, Kupper H, Ballal S, Gibson E, Wong R (2009) Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years. Arthritis Res Ther 11:R127. doi:10.1186/ar2794

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • van der Helm-van Mil AH, Huizinga TW, Schreuder GM, Breedveld FC, de Vries RR, Toes RE (2005) An independent role of protective hla class ii alleles in rheumatoid arthritis severity and susceptibility. Arthritis Rheum 52:2637–2644

    Article  CAS  Google Scholar 

  • van der Helm-van Mil AHM, Huizinga TWJ, de Vries RRP, Toes REM (2007) Emerging patterns of risk factor make-up enable subclassification of rheumatoid arthritis. Arthritis Rheum 56:1728–1735

    Article  CAS  Google Scholar 

  • van der Linden SM, Valkenburg HA, de Jongh BM, Cats A (1984) The risk of developing ankylosing spondylitis in hla-b27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 27:241–249

    Article  PubMed  Google Scholar 

  • van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C (2006) Clinical assessment of the long- term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54:3104–3112

    Article  PubMed  Google Scholar 

  • van Vollenhoven RF, Fleischmann R, Cohen S, Lee EB, García Meijide JA, Wagner S, Forejtova S, Zwillich SH, Gruben D, Koncz T, Wallenstein GV, Krishnaswami S, Bradley JD, Wilkinson B, ORAL Standard Investigators (2012) Tofacitinib or adalimumab versus placebo in rheumatoid arthritis. N Engl J Med 367:508–519

    Article  PubMed  CAS  Google Scholar 

  • Veale DJ (2013) Psoriatic arthritis: recent progress in pathophysiology and drug development. Arthritis Res Ther 15:224

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Vis M, Haavardsholm EA, Boyesen P et al (2011) High incidence of vertebral and non vertebral fractures in the OSTRA cohort study: a 5 year follow up study in postmenopausal women with rheumatoid arthritis. Osteoporos Int 22(9):2413–2419

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wagner UG, Koetz K, Weyand CM, Goronzy JJ (1998) Perturbation of the t cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A 95:14447–14452

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wesoly J, van der Helm-van Mil AHM, Toes REM, Chokkalingam AP, Carlton VEH, Begovich AB, Huizinga TWJ (2005) Association of the ptpn22 c1858t single- nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohort. Arthritis Rheum 52:2948–2950

    Article  CAS  PubMed  Google Scholar 

  • Weyand CM, Hicok KC, Conn DL, Goronzy JJ (1992) The influence of hla-drb1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 117:801–803

    Article  CAS  PubMed  Google Scholar 

  • Wright NC, Lisse JR, Walitt BT, Eaton CB, Chen Z (2011) Arthritis increases the risk for fractures—results from the Women’s Health Initiative. J Rheumatol 38:1680–1688

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhang G, Luo J, Bruckel J, Weisman MA, Schumacher HR, Khan MA, Inman RD, Mahowald M, Maksymowych WP, Martin TM, Yu DTY, Stone M, Rosenbaum JT, Newman P, Lee J, McClain JA, West OC, Jin L, Reveille JD (2004) Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum 50:2246–2254

    Article  CAS  PubMed  Google Scholar 

  • Zhu TY, Griffith JF, Qin L, Hung VW, Fong TN, Au SK, Tang XL, Kwok AW, Leung PC, Li EK, Tam LS (2013) Structure and strength of the distal radius in female patients with rheumatoid arthritis: a case–control study. J Bone Miner Res 28(4):794–806

    Article  PubMed  Google Scholar 

  • Zhu TY, Griffith JF, Qin L, Hung VW, Fong TN, Au SK, Li M, Lam YY, Wong CK, Kwok AW, Leung PC, Li EK, Tam LS (2014) Alterations of bone density, microstructure, and strength of the distal radius in male patients with rheumatoid arthritis: a case–control study with HR-pQCT. J Bone Miner Res 29(9):2118–2129

    Article  CAS  PubMed  Google Scholar 

  • Zochling J, van der Heijde D, Dougados M, Braun J (2006) Current evidence for the management of ankylosing spondylitis: a systematic literature review for the asas/eular management recommendations in ankylosing spondylitis. Ann Rheum Dis 65:423–432

    Article  CAS  PubMed  Google Scholar 

  • Zvaifler NJ (1973) The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol 16:265–336

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology Department, Waikato Hospital, Pembroke Street, Hamilton, New Zealand

    Douglas H. N. White M.D., BSc, MBChB, FRACP

  2. Medical Department II, St. Vincent Hospital Vienna, Academic Teaching Hospital of the Medical University Vienna, Vienna, Austria

    Roland Kocijan M.D.

Authors
  1. Douglas H. N. White M.D., BSc, MBChB, FRACP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roland Kocijan M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Douglas H. N. White M.D., BSc, MBChB, FRACP .

Editor information

Editors and Affiliations

  1. Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria

    Peter Pietschmann

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

White, D.H.N., Kocijan, R. (2016). Rheumatoid Arthritis and Spondyloarthritis. In: Pietschmann, P. (eds) Principles of Osteoimmunology. Springer, Cham. https://doi.org/10.1007/978-3-319-34238-2_8

Download citation

Publish with us

Policies and ethics

Search

Navigation